S.B. No. 493 aims to enhance the protection of disclosures and communications made by pharmacists and pharmacies regarding prescription drug benefits. The bill introduces a new section, 4151.155, to the Insurance Code, which prohibits pharmacy benefit managers from restricting pharmacists or pharmacies from informing enrollees about the differences in out-of-pocket costs for prescription drugs under their benefits compared to costs without submitting a claim. Additionally, any contract provision that attempts to impose such restrictions is deemed void and unenforceable. The bill also allows pharmacists to communicate with plan sponsors or administrators about various aspects of prescription drug benefits and pharmacy services.

The changes enacted by this bill will apply only to contracts or agreements that are entered into, amended, or renewed on or after its effective date of September 1, 2025. This legislation is designed to promote transparency and ensure that enrollees are fully informed about their prescription drug costs, ultimately enhancing patient care and decision-making.

Statutes affected:
Introduced: ()
Senate Committee Report: ()
Engrossed: ()
House Committee Report: ()
Enrolled: ()